1-855-378-42281-855-378-4228
One of the outpatient rehabilitation options for clients in Stewartsville who are struggling with opioid abuse and addiction is opioid maintenance therapy. Licensed clinics and doctors are certified to dispense specific medications to opioid dependent clients, many of which are opioid-based themselves and are addiction. In low doses however, the user does not experience high feelings but also doesn't experience acute cravings and isn't in opioid withdrawal. Methadone is the first med administered for this reason, but there are a few more options currently to choose from.
Methadone is an opiate and can be taken at an outpatient medical center certified to dispense the med, which is taken on a daily basis as a pill or liquid. The price of the med is approximately $150 per month. Buprenorphine is also an opioid-based drug, and is in pill form often taken one day on, one day off. But unlike Methadone which is only be administered in highly structured medical centers, Buprenorphine can be prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is approximately three hundred dollars /month for the generic of the medication. There is also a type of buprenorphine that contains naloxone, that is a med that blocks the effects of opioids. Someone taking this version of the drug, AKA Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken every day, and costs approximately $450 /month. Naltrexone is an additional med taken in opioid maintenance therapy, but unlike the other drugs aforementioned it is an opioid blocker and isn't an opioid. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents an individual from experience high feelings from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 /month.
For All Alcohol and Drug Rehabilitation Programs In Stewartsville, Click Here.
